Product Information
POTASSIUM CL ER 10 MEQ TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1272 per EA under NDC 72603033701. Its NADAC has been published 96 times since Dec 4, 2024.
FDA first approved this application on Dec 29, 2020. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603033701
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214422FDA Approved
12/29/2020
TE Code
AB1
On Market Since
6/21/2024
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 10 MEQ TABLET has been published 96 times since Dec 4, 2024, and over the history we have for it it has risen 33.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1272 per EA |
|---|---|
| All-time high | $0.1380 (Jun 10, 2026) |
| All-time low | $0.0951 (Dec 4, 2024) |
| 52-week high | $0.1380 |
| 52-week low | $0.1186 |
| Median price | $0.1274 |
| Average price | $0.1259 |
| Largest weekly change | +15.6% (Dec 18, 2024) |
| Weeks tracked | 96 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
potassium chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 10 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 10 MEQ TABLET, manufactured by NorthStar Rx LLC, is $0.1272 per EA (NDC 72603033701), effective Sep 30, 2026.
How has the price of POTASSIUM CL ER 10 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has risen 33.8%. It has been tracked across 96 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 10 MEQ TABLET?
Since Dec 4, 2024, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has ranged from a low of $0.0951 (Dec 4, 2024) to a high of $0.1380 (Jun 10, 2026), with a median of $0.1274 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 10 MEQ TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 10 MEQ TABLET, is $0.0828 per EA — about 35% below POTASSIUM CL ER 10 MEQ TABLET.
Who manufactures POTASSIUM CL ER 10 MEQ TABLET?
POTASSIUM CL ER 10 MEQ TABLET (NDC 72603033701) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.